INVO Bioscience Inc.

NASDAQ: INVO · Real-Time Price · USD
0.83
-0.02 (-2.35%)
At close: Oct 21, 2024, 10:00 PM

INVO Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
741.4M 232.42K 90.14K 5.68M
Short-Term Investments
n/a -2.17M n/a n/a
Long-Term Investments
740.76M 3.09M 1.24M 1.49M
Other Long-Term Assets
2.28B 7.91M -3.48M 3.53M
Receivables
174.88M 140.55K 77.15K 50.47K
Inventory
219.76M 264.51K 263.6K 287.77K
Other Current Assets
182.29M 622.29K 190.2K 282.75K
Total Current Assets
1.32B 1.26M 621.09K 6.31M
Property-Plant & Equipment
466.68M 6.57M 2.24M 2.54M
Goodwill & Intangibles
41.64B 9.97M n/a 132.09K
Total Long-Term Assets
45.13B 19.63M 3.48M 4.16M
Total Assets
46.45B 20.89M 4.1M 10.47M
Account Payables
n/a 2.33M 1.35M 443.42K
Deferred Revenue
602.36M 408.77K 119.88K 5.9K
Short-Term Debt
7.46B 1.51M 994.25K 221.99K
Other Current Liabilities
9.87B 3.57M 119.88K 359.7K
Total Current Liabilities
17.93B 8.22M 3.41M 1.25M
Long-Term Debt
3.32B 1.25M n/a n/a
Other Long-Term Liabilities
5B 5M n/a n/a
Total Long-Term Liabilities
8.32B 11.78M 1.67M 1.9M
Total Liabilities
26.24B 19.99M 5.08M 3.16M
Total Debt
10.78B 8.68M 2.66M 2.12M
Common Stock
37K 249.00 1.22K 1.19K
Retained Earnings
-67.16B -57.82M -49.78M -38.89M
Comprehensive Income
n/a -6M -0.00 n/a
Shareholders Equity
12.75B 892.83K -977.61K 7.31M
Total Investments
n/a 916.25K 1.24M 1.49M